Sorting out the evidence on natriuretic peptides

Reviews in Cardiovascular Medicine

Volumn 4, Issue SUPPL. 4, 2003, Pages

  McCullough, Peter A ^a   Sandberg, Keisha R ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Acute coronary syndromes; B type natriuretic peptide; Heart failure; N terminal proBNP; Prognosis; Sudden death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROHORMONE;

ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE WALL; HUMAN; KIDNEY CLEARANCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MEDICAL LITERATURE; MUSCLE STRETCHING; PLASMA HALF LIFE; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN SECRETION; SUDDEN DEATH;

BIOLOGICAL MARKERS; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PREVALENCE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0141925928     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 2002;39:60-69.
2. Stevenson LW. The limited availability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884-888.
3. Vinson JM, Rich MW, Sperry JC, et al. Early readmission of elderly patients with heart failure. J Am Geriatr Soc. 1990;38:1290-1295.
4. Grantham JA, Burnett JC Jr. BNP: increasing importance in the pathophysiology and diagnosis of congestive heart failure. Circulation. 1997;96:388-390.
5. Grantham JA, Borgeson DD, Burnett JC. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure. Am J Physiol. 1997;92:R1077-R1083.
6. Klinge R, Hystad M, Kjekshus J, et al. An experimental study of cardiac natriuretic peptides as markers of development of HF. Scand J Clin Lab Invest. 1998;58:683-691.
7. Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol. 1998;274:H1684-H1689.
8. Stingo AJ, Clavell AL, Heublein DM, et al. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 1992;263:H1318-H1321.
9. Nagagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy. Evidence for BNP as an "emergency" cardiac hormone against ventricular overload. J Clin Invest. 1995;96:1280-1287.
10. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997;96:509-516.
11. Maeda K, Takayoshi T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135:825-832.
12. Muders F, Kromer EP, Griese DP, et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J. 1997;134:442-449.
13. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195-203.
14. Roche Diagnostics. ProBrain natriuretic peptide package insert. Indianapolis: Roche Diagnostics; 2002.
15. Biosite. TriageBNP package insert. San Diego: Biosite; 2002.
16. Kazanegra R, Cheng V, Garcia A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail. 2001;7:21-9.
17. Haug C, Metzele A, Steffen J, et al. Increased brain natriuretic peptide and atrial peptide plasma concentration in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Invest. 1994;72:430-434.
18. Ishizaka Y, Yamamoto Y, Tanaka M, et al. Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD). Clin Nephrol. 1995;43:237-242.
19. Sengstock D, Pasnoori V, Obaidat O, et al. Asthma, beta-agonists, and the development of congestive heart failure: results of the ABCHF study. J Card Fail. 2002;8:232-238.
20. McCullough PA, Hollander JE, Nowak RM, et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med. 2003;10:198-204.
21. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002;90:254-258.
22. Maisel AS, McCord J, Nowak RM, et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure. J Am Coll Cardiol. 2003;(41)2010-2017.
23. Omland T, Knudsen CW, Westheim A, et al. The effect of hypertension on B-type natriuretic peptide levels in patients with acute dyspnea: an analysis from the Breathing Not Properly study. Circulation. 2002;106:II-477.
24. Maisel AS, Kazanegra R, McCord J, et al. The effect of diabetes on B-type natriuretic peptide levels in patients with acute dyspnea [abstract]. J Am Coll Cardiol. 2002;39:182A.
25. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis. 2003;41:571-579.
26. Krishnaswamy PB, Lubien E, Kazanegra R, et al. BNP can differentiate normal LV function from diastolic dysfunction in patients with clinical congestive heart failure [abstract]. J Am Coll Cardiol. 2001;(2):210A.
27. Hammerer-Lercher A, Neubauer E, Muller S, et al. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta. 2001;310:193-197.
28. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
29. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in the emergency diagnosis of heart failure: analysis from the Breathing Not Properly (BNP) Multinational Study. Circulation. 2002; 106:416-422.
30. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction. Circulation. 2002;105:595-601.
31. Maeda K, Tsutamoto T, Wada A, et al. High level of plasma BNP at discharge is an independent risk factor for mortality and morbidity in patients with congestive heart failure. J Am Coll Cardiol. 1999;192A:1113-1140.
32. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392-2397.
33. Wallen T, Landahl S, Hedner T, et al. Brain natriuretic peptide predicts mortality in the elderly. Heart. 1997;77:264-267.
34. Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 1998;97:1921-1929.
35. Kikuta K, Yasue H, Yoshimura M, et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J. 1996;132:101-107.
36. Talwar S, Squire IB, Downie PF, et al. Plasma N-terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart. 2000;84:421-424.
37. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014-1021.
38. Omland T, Persson A, Ng L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 2002;106:2913-2918.